Adenylyl cyclase VI mediates vasopressin-stimulated ENaC activity. 2013

Karl P Roos, and Vladislav Bugaj, and Elena Mironova, and James D Stockand, and Nirupama Ramkumar, and Sara Rees, and Donald E Kohan
Division of Nephrology, University of Utah Health Sciences Center, Salt Lake City, UT 84132, USA.

Vasopressin modulates sodium reabsorption in the collecting duct through adenylyl cyclase-stimulated cyclic AMP, which exists as multiple isoforms; the specific isoform involved in vasopressin-stimulated sodium transport is unknown. To assess this, we studied mice deficient in adenylyl cyclase type VI specifically in the principal cells of the collecting duct. Knockout mice had increased urine volume and reduced urine sodium concentration, but regardless of the level of sodium intake, they did not exhibit significant alterations in urinary sodium excretion, arterial pressure, or pulse rate. Plasma renin concentration was elevated in knockout mice, however, suggesting a compensatory response. Valsartan significantly reduced arterial pressure in knockout mice but not in controls. Knockout mice had decreased renal cortical mRNA content of all three epithelial sodium channel (ENaC) isoforms, and total cell sodium channel isoforms α and γ were reduced in these animals. Patch-clamp analysis of split-open cortical collecting ducts revealed no difference in baseline activity of sodium channels, but knockout mice had abolished vasopressin-stimulated ENaC open probability and apical membrane channel number. In summary, these data suggest that adenylyl cyclase VI mediates vasopressin-stimulated ENaC activity in the kidney.

UI MeSH Term Description Entries
D007685 Kidney Tubules, Collecting Straight tubes commencing in the radiate part of the kidney cortex where they receive the curved ends of the distal convoluted tubules. In the medulla the collecting tubules of each pyramid converge to join a central tube (duct of Bellini) which opens on the summit of the papilla. Kidney Collecting Ducts,Kidney Collecting Duct,Collecting Duct, Kidney,Collecting Ducts, Kidney
D008297 Male Males
D012083 Renin A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19. Angiotensin-Forming Enzyme,Angiotensinogenase,Big Renin,Cryorenin,Inactive Renin,Pre-Prorenin,Preprorenin,Prorenin,Angiotensin Forming Enzyme,Pre Prorenin,Renin, Big,Renin, Inactive
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D005260 Female Females
D006339 Heart Rate The number of times the HEART VENTRICLES contract per unit of time, usually per minute. Cardiac Rate,Chronotropism, Cardiac,Heart Rate Control,Heartbeat,Pulse Rate,Cardiac Chronotropy,Cardiac Chronotropism,Cardiac Rates,Chronotropy, Cardiac,Control, Heart Rate,Heart Rates,Heartbeats,Pulse Rates,Rate Control, Heart,Rate, Cardiac,Rate, Heart,Rate, Pulse
D000068756 Valsartan A tetrazole derivative and ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKER that is used to treat HYPERTENSION. CGP 48933,Diovan,Kalpress,Miten,N-valeryl-N-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)valine,Nisis,Provas,Tareg,Vals,48933, CGP
D000262 Adenylyl Cyclases Enzymes of the lyase class that catalyze the formation of CYCLIC AMP and pyrophosphate from ATP. Adenyl Cyclase,Adenylate Cyclase,3',5'-cyclic AMP Synthetase,Adenylyl Cyclase,3',5' cyclic AMP Synthetase,AMP Synthetase, 3',5'-cyclic,Cyclase, Adenyl,Cyclase, Adenylate,Cyclase, Adenylyl,Cyclases, Adenylyl,Synthetase, 3',5'-cyclic AMP
D000450 Aldosterone A hormone secreted by the ADRENAL CORTEX that regulates electrolyte and water balance by increasing the renal retention of sodium and the excretion of potassium. Aldosterone, (+-)-Isomer,Aldosterone, (11 beta,17 alpha)-Isomer
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Karl P Roos, and Vladislav Bugaj, and Elena Mironova, and James D Stockand, and Nirupama Ramkumar, and Sara Rees, and Donald E Kohan
February 2002, Nature neuroscience,
Karl P Roos, and Vladislav Bugaj, and Elena Mironova, and James D Stockand, and Nirupama Ramkumar, and Sara Rees, and Donald E Kohan
July 1996, Molecular pharmacology,
Karl P Roos, and Vladislav Bugaj, and Elena Mironova, and James D Stockand, and Nirupama Ramkumar, and Sara Rees, and Donald E Kohan
January 2013, The American journal of pathology,
Karl P Roos, and Vladislav Bugaj, and Elena Mironova, and James D Stockand, and Nirupama Ramkumar, and Sara Rees, and Donald E Kohan
October 1983, Biochemical and biophysical research communications,
Karl P Roos, and Vladislav Bugaj, and Elena Mironova, and James D Stockand, and Nirupama Ramkumar, and Sara Rees, and Donald E Kohan
April 1981, Canadian journal of biochemistry,
Karl P Roos, and Vladislav Bugaj, and Elena Mironova, and James D Stockand, and Nirupama Ramkumar, and Sara Rees, and Donald E Kohan
October 1999, Pharmacology & toxicology,
Karl P Roos, and Vladislav Bugaj, and Elena Mironova, and James D Stockand, and Nirupama Ramkumar, and Sara Rees, and Donald E Kohan
August 1997, The American journal of physiology,
Karl P Roos, and Vladislav Bugaj, and Elena Mironova, and James D Stockand, and Nirupama Ramkumar, and Sara Rees, and Donald E Kohan
June 2007, Electrophoresis,
Karl P Roos, and Vladislav Bugaj, and Elena Mironova, and James D Stockand, and Nirupama Ramkumar, and Sara Rees, and Donald E Kohan
June 1977, Biochimica et biophysica acta,
Karl P Roos, and Vladislav Bugaj, and Elena Mironova, and James D Stockand, and Nirupama Ramkumar, and Sara Rees, and Donald E Kohan
September 1999, Molecular pharmacology,
Copied contents to your clipboard!